nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluconazole—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0987	0.14	CbGbCtD
Fluconazole—CYP3A7—Progesterone—uterine cancer	0.0987	0.14	CbGbCtD
Fluconazole—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.075	0.106	CbGbCtD
Fluconazole—CYP3A5—Progesterone—uterine cancer	0.0741	0.105	CbGbCtD
Fluconazole—CYP2C19—Progesterone—uterine cancer	0.0597	0.0846	CbGbCtD
Fluconazole—CYP2C9—Progesterone—uterine cancer	0.0497	0.0704	CbGbCtD
Fluconazole—ABCB1—Progesterone—uterine cancer	0.0482	0.0683	CbGbCtD
Fluconazole—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0436	0.0618	CbGbCtD
Fluconazole—ABCB1—Dactinomycin—uterine cancer	0.0382	0.0541	CbGbCtD
Fluconazole—CYP3A5—Etoposide—uterine cancer	0.0331	0.0469	CbGbCtD
Fluconazole—CYP3A4—Progesterone—uterine cancer	0.0289	0.0409	CbGbCtD
Fluconazole—ABCB1—Etoposide—uterine cancer	0.0216	0.0306	CbGbCtD
Fluconazole—ABCB1—Doxorubicin—uterine cancer	0.0147	0.0208	CbGbCtD
Fluconazole—CYP3A4—Etoposide—uterine cancer	0.0129	0.0183	CbGbCtD
Fluconazole—CYP3A4—Doxorubicin—uterine cancer	0.00882	0.0125	CbGbCtD
Fluconazole—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000329	0.00131	CcSEcCtD
Fluconazole—Flushing—Etoposide—uterine cancer	0.000327	0.00131	CcSEcCtD
Fluconazole—Cardiac disorder—Etoposide—uterine cancer	0.000327	0.00131	CcSEcCtD
Fluconazole—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000327	0.00131	CcSEcCtD
Fluconazole—Dizziness—Progesterone—uterine cancer	0.000324	0.0013	CcSEcCtD
Fluconazole—Angiopathy—Etoposide—uterine cancer	0.00032	0.00128	CcSEcCtD
Fluconazole—Vascular purpura—Epirubicin—uterine cancer	0.00032	0.00128	CcSEcCtD
Fluconazole—Hypertonia—Doxorubicin—uterine cancer	0.000319	0.00128	CcSEcCtD
Fluconazole—Immune system disorder—Etoposide—uterine cancer	0.000319	0.00127	CcSEcCtD
Fluconazole—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000319	0.00127	CcSEcCtD
Fluconazole—Hepatic failure—Epirubicin—uterine cancer	0.000318	0.00127	CcSEcCtD
Fluconazole—Mediastinal disorder—Etoposide—uterine cancer	0.000318	0.00127	CcSEcCtD
Fluconazole—Abnormal vision—Doxorubicin—uterine cancer	0.000318	0.00127	CcSEcCtD
Fluconazole—Chills—Etoposide—uterine cancer	0.000317	0.00127	CcSEcCtD
Fluconazole—Sepsis—Doxorubicin—uterine cancer	0.000316	0.00126	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000315	0.00126	CcSEcCtD
Fluconazole—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000314	0.00126	CcSEcCtD
Fluconazole—Alopecia—Etoposide—uterine cancer	0.000312	0.00125	CcSEcCtD
Fluconazole—Vomiting—Progesterone—uterine cancer	0.000311	0.00125	CcSEcCtD
Fluconazole—Rash—Progesterone—uterine cancer	0.000309	0.00124	CcSEcCtD
Fluconazole—Dermatitis—Progesterone—uterine cancer	0.000309	0.00123	CcSEcCtD
Fluconazole—Headache—Progesterone—uterine cancer	0.000307	0.00123	CcSEcCtD
Fluconazole—Hot flush—Epirubicin—uterine cancer	0.000306	0.00122	CcSEcCtD
Fluconazole—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000304	0.00122	CcSEcCtD
Fluconazole—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000304	0.00121	CcSEcCtD
Fluconazole—Menopausal symptoms—Epirubicin—uterine cancer	0.000303	0.00121	CcSEcCtD
Fluconazole—Decreased appetite—Dactinomycin—uterine cancer	0.000301	0.0012	CcSEcCtD
Fluconazole—Dysgeusia—Etoposide—uterine cancer	0.000301	0.0012	CcSEcCtD
Fluconazole—Fatigue—Dactinomycin—uterine cancer	0.000299	0.00119	CcSEcCtD
Fluconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000298	0.00677	CbGpPWpGaD
Fluconazole—Back pain—Etoposide—uterine cancer	0.000297	0.00119	CcSEcCtD
Fluconazole—Purpura—Epirubicin—uterine cancer	0.000297	0.00119	CcSEcCtD
Fluconazole—Pain—Dactinomycin—uterine cancer	0.000296	0.00118	CcSEcCtD
Fluconazole—Vascular purpura—Doxorubicin—uterine cancer	0.000296	0.00118	CcSEcCtD
Fluconazole—Hepatic failure—Doxorubicin—uterine cancer	0.000294	0.00118	CcSEcCtD
Fluconazole—CYP3A5—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000294	0.00669	CbGpPWpGaD
Fluconazole—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000294	0.00117	CcSEcCtD
Fluconazole—CYP3A7—Metapathway biotransformation—AKR1B1—uterine cancer	0.000292	0.00665	CbGpPWpGaD
Fluconazole—Nausea—Progesterone—uterine cancer	0.000291	0.00116	CcSEcCtD
Fluconazole—Feeling abnormal—Dactinomycin—uterine cancer	0.000285	0.00114	CcSEcCtD
Fluconazole—Ill-defined disorder—Etoposide—uterine cancer	0.000285	0.00114	CcSEcCtD
Fluconazole—Anaemia—Etoposide—uterine cancer	0.000284	0.00113	CcSEcCtD
Fluconazole—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000283	0.00113	CcSEcCtD
Fluconazole—Hot flush—Doxorubicin—uterine cancer	0.000283	0.00113	CcSEcCtD
Fluconazole—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000282	0.00113	CcSEcCtD
Fluconazole—Menopausal symptoms—Doxorubicin—uterine cancer	0.00028	0.00112	CcSEcCtD
Fluconazole—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00028	0.00112	CcSEcCtD
Fluconazole—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00028	0.00112	CcSEcCtD
Fluconazole—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000278	0.00111	CcSEcCtD
Fluconazole—Malaise—Etoposide—uterine cancer	0.000277	0.00111	CcSEcCtD
Fluconazole—Face oedema—Epirubicin—uterine cancer	0.000276	0.0011	CcSEcCtD
Fluconazole—Vertigo—Etoposide—uterine cancer	0.000276	0.0011	CcSEcCtD
Fluconazole—Leukopenia—Etoposide—uterine cancer	0.000275	0.0011	CcSEcCtD
Fluconazole—Purpura—Doxorubicin—uterine cancer	0.000274	0.0011	CcSEcCtD
Fluconazole—Abdominal pain—Dactinomycin—uterine cancer	0.000274	0.00109	CcSEcCtD
Fluconazole—Body temperature increased—Dactinomycin—uterine cancer	0.000274	0.00109	CcSEcCtD
Fluconazole—Ataxia—Epirubicin—uterine cancer	0.000269	0.00107	CcSEcCtD
Fluconazole—Convulsion—Etoposide—uterine cancer	0.000266	0.00106	CcSEcCtD
Fluconazole—CYP11B1—Biological oxidations—CYP19A1—uterine cancer	0.000265	0.00603	CbGpPWpGaD
Fluconazole—Hypertension—Etoposide—uterine cancer	0.000265	0.00106	CcSEcCtD
Fluconazole—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000264	0.00105	CcSEcCtD
Fluconazole—Dry skin—Epirubicin—uterine cancer	0.000262	0.00105	CcSEcCtD
Fluconazole—CYP11B1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000262	0.00595	CbGpPWpGaD
Fluconazole—Hypokalaemia—Epirubicin—uterine cancer	0.00026	0.00104	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00026	0.00104	CcSEcCtD
Fluconazole—Discomfort—Etoposide—uterine cancer	0.000258	0.00103	CcSEcCtD
Fluconazole—Breast disorder—Epirubicin—uterine cancer	0.000258	0.00103	CcSEcCtD
Fluconazole—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000257	0.00103	CcSEcCtD
Fluconazole—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000257	0.00103	CcSEcCtD
Fluconazole—Face oedema—Doxorubicin—uterine cancer	0.000255	0.00102	CcSEcCtD
Fluconazole—Hypersensitivity—Dactinomycin—uterine cancer	0.000255	0.00102	CcSEcCtD
Fluconazole—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000252	0.00101	CcSEcCtD
Fluconazole—CYP2C19—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000252	0.00572	CbGpPWpGaD
Fluconazole—Anaphylactic shock—Etoposide—uterine cancer	0.000251	0.001	CcSEcCtD
Fluconazole—Ataxia—Doxorubicin—uterine cancer	0.000249	0.000994	CcSEcCtD
Fluconazole—Asthenia—Dactinomycin—uterine cancer	0.000248	0.000993	CcSEcCtD
Fluconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000246	0.00559	CbGpPWpGaD
Fluconazole—Thrombocytopenia—Etoposide—uterine cancer	0.000245	0.000981	CcSEcCtD
Fluconazole—Skin disorder—Etoposide—uterine cancer	0.000243	0.000973	CcSEcCtD
Fluconazole—Dry skin—Doxorubicin—uterine cancer	0.000242	0.000969	CcSEcCtD
Fluconazole—Hyperhidrosis—Etoposide—uterine cancer	0.000242	0.000969	CcSEcCtD
Fluconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000241	0.00549	CbGpPWpGaD
Fluconazole—Hypokalaemia—Doxorubicin—uterine cancer	0.000241	0.000962	CcSEcCtD
Fluconazole—Breast disorder—Doxorubicin—uterine cancer	0.000239	0.000956	CcSEcCtD
Fluconazole—Anorexia—Etoposide—uterine cancer	0.000239	0.000955	CcSEcCtD
Fluconazole—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000238	0.000952	CcSEcCtD
Fluconazole—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000238	0.000952	CcSEcCtD
Fluconazole—Diarrhoea—Dactinomycin—uterine cancer	0.000237	0.000947	CcSEcCtD
Fluconazole—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000233	0.000933	CcSEcCtD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000231	0.00526	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000231	0.00526	CbGpPWpGaD
Fluconazole—Neutropenia—Epirubicin—uterine cancer	0.000231	0.000924	CcSEcCtD
Fluconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00023	0.00524	CbGpPWpGaD
Fluconazole—CYP2C9—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000229	0.00522	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—AKR1B10—uterine cancer	0.000227	0.00517	CbGpPWpGaD
Fluconazole—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000227	0.00517	CbGpPWpGaD
Fluconazole—Paraesthesia—Etoposide—uterine cancer	0.000225	0.0009	CcSEcCtD
Fluconazole—Somnolence—Etoposide—uterine cancer	0.000223	0.000891	CcSEcCtD
Fluconazole—Infestation NOS—Epirubicin—uterine cancer	0.00022	0.000881	CcSEcCtD
Fluconazole—Infestation—Epirubicin—uterine cancer	0.00022	0.000881	CcSEcCtD
Fluconazole—Vomiting—Dactinomycin—uterine cancer	0.00022	0.00088	CcSEcCtD
Fluconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000219	0.00498	CbGpPWpGaD
Fluconazole—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000218	0.000873	CcSEcCtD
Fluconazole—Rash—Dactinomycin—uterine cancer	0.000218	0.000873	CcSEcCtD
Fluconazole—Decreased appetite—Etoposide—uterine cancer	0.000218	0.000871	CcSEcCtD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000217	0.00494	CbGpPWpGaD
Fluconazole—Gastrointestinal disorder—Etoposide—uterine cancer	0.000216	0.000865	CcSEcCtD
Fluconazole—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000216	0.00492	CbGpPWpGaD
Fluconazole—Fatigue—Etoposide—uterine cancer	0.000216	0.000864	CcSEcCtD
Fluconazole—Stomatitis—Epirubicin—uterine cancer	0.000215	0.000859	CcSEcCtD
Fluconazole—Jaundice—Epirubicin—uterine cancer	0.000215	0.000859	CcSEcCtD
Fluconazole—CYP3A7—Metapathway biotransformation—AKR1C1—uterine cancer	0.000215	0.00488	CbGpPWpGaD
Fluconazole—Pain—Etoposide—uterine cancer	0.000214	0.000857	CcSEcCtD
Fluconazole—Constipation—Etoposide—uterine cancer	0.000214	0.000857	CcSEcCtD
Fluconazole—Neutropenia—Doxorubicin—uterine cancer	0.000214	0.000855	CcSEcCtD
Fluconazole—CYP3A5—Metapathway biotransformation—AKR1B1—uterine cancer	0.000211	0.00481	CbGpPWpGaD
Fluconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00021	0.00478	CbGpPWpGaD
Fluconazole—Hepatobiliary disease—Epirubicin—uterine cancer	0.000208	0.000833	CcSEcCtD
Fluconazole—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000207	0.00471	CbGpPWpGaD
Fluconazole—Feeling abnormal—Etoposide—uterine cancer	0.000207	0.000826	CcSEcCtD
Fluconazole—Nausea—Dactinomycin—uterine cancer	0.000206	0.000822	CcSEcCtD
Fluconazole—Agranulocytosis—Epirubicin—uterine cancer	0.000206	0.000822	CcSEcCtD
Fluconazole—Gastrointestinal pain—Etoposide—uterine cancer	0.000205	0.000819	CcSEcCtD
Fluconazole—Infestation—Doxorubicin—uterine cancer	0.000204	0.000815	CcSEcCtD
Fluconazole—Infestation NOS—Doxorubicin—uterine cancer	0.000204	0.000815	CcSEcCtD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—CXCL8—uterine cancer	0.000203	0.00463	CbGpPWpGaD
Fluconazole—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000202	0.000808	CcSEcCtD
Fluconazole—Urticaria—Etoposide—uterine cancer	0.000199	0.000796	CcSEcCtD
Fluconazole—Stomatitis—Doxorubicin—uterine cancer	0.000199	0.000794	CcSEcCtD
Fluconazole—Jaundice—Doxorubicin—uterine cancer	0.000199	0.000794	CcSEcCtD
Fluconazole—Abdominal pain—Etoposide—uterine cancer	0.000198	0.000792	CcSEcCtD
Fluconazole—Body temperature increased—Etoposide—uterine cancer	0.000198	0.000792	CcSEcCtD
Fluconazole—Pharyngitis—Epirubicin—uterine cancer	0.000196	0.000785	CcSEcCtD
Fluconazole—Urinary tract disorder—Epirubicin—uterine cancer	0.000195	0.000781	CcSEcCtD
Fluconazole—Connective tissue disorder—Epirubicin—uterine cancer	0.000194	0.000777	CcSEcCtD
Fluconazole—Urethral disorder—Epirubicin—uterine cancer	0.000194	0.000775	CcSEcCtD
Fluconazole—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000193	0.000771	CcSEcCtD
Fluconazole—Visual impairment—Epirubicin—uterine cancer	0.000191	0.000762	CcSEcCtD
Fluconazole—Agranulocytosis—Doxorubicin—uterine cancer	0.00019	0.000761	CcSEcCtD
Fluconazole—CYP3A7—Metapathway biotransformation—GPX3—uterine cancer	0.000188	0.00429	CbGpPWpGaD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—CTNNB1—uterine cancer	0.000188	0.00427	CbGpPWpGaD
Fluconazole—Erythema multiforme—Epirubicin—uterine cancer	0.000187	0.000748	CcSEcCtD
Fluconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000187	0.00425	CbGpPWpGaD
Fluconazole—Eye disorder—Epirubicin—uterine cancer	0.000185	0.000739	CcSEcCtD
Fluconazole—Hypersensitivity—Etoposide—uterine cancer	0.000185	0.000738	CcSEcCtD
Fluconazole—Flushing—Epirubicin—uterine cancer	0.000184	0.000734	CcSEcCtD
Fluconazole—Cardiac disorder—Epirubicin—uterine cancer	0.000184	0.000734	CcSEcCtD
Fluconazole—Pharyngitis—Doxorubicin—uterine cancer	0.000182	0.000726	CcSEcCtD
Fluconazole—Urinary tract disorder—Doxorubicin—uterine cancer	0.000181	0.000722	CcSEcCtD
Fluconazole—Asthenia—Etoposide—uterine cancer	0.00018	0.000719	CcSEcCtD
Fluconazole—Connective tissue disorder—Doxorubicin—uterine cancer	0.00018	0.000719	CcSEcCtD
Fluconazole—Angiopathy—Epirubicin—uterine cancer	0.000179	0.000717	CcSEcCtD
Fluconazole—Urethral disorder—Doxorubicin—uterine cancer	0.000179	0.000717	CcSEcCtD
Fluconazole—Immune system disorder—Epirubicin—uterine cancer	0.000179	0.000714	CcSEcCtD
Fluconazole—Mediastinal disorder—Epirubicin—uterine cancer	0.000178	0.000713	CcSEcCtD
Fluconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000178	0.00404	CbGpPWpGaD
Fluconazole—Chills—Epirubicin—uterine cancer	0.000177	0.000709	CcSEcCtD
Fluconazole—CYP3A7—Biological oxidations—CYP11A1—uterine cancer	0.000177	0.00404	CbGpPWpGaD
Fluconazole—Pruritus—Etoposide—uterine cancer	0.000177	0.000709	CcSEcCtD
Fluconazole—Visual impairment—Doxorubicin—uterine cancer	0.000176	0.000705	CcSEcCtD
Fluconazole—CYP2C19—Metapathway biotransformation—AKR1B10—uterine cancer	0.000176	0.004	CbGpPWpGaD
Fluconazole—CYP3A7—Metapathway biotransformation—CYP11A1—uterine cancer	0.000175	0.00398	CbGpPWpGaD
Fluconazole—Alopecia—Epirubicin—uterine cancer	0.000175	0.000699	CcSEcCtD
Fluconazole—Mental disorder—Epirubicin—uterine cancer	0.000173	0.000693	CcSEcCtD
Fluconazole—Erythema multiforme—Doxorubicin—uterine cancer	0.000173	0.000692	CcSEcCtD
Fluconazole—Malnutrition—Epirubicin—uterine cancer	0.000172	0.000688	CcSEcCtD
Fluconazole—Diarrhoea—Etoposide—uterine cancer	0.000171	0.000686	CcSEcCtD
Fluconazole—Eye disorder—Doxorubicin—uterine cancer	0.000171	0.000684	CcSEcCtD
Fluconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00017	0.00387	CbGpPWpGaD
Fluconazole—Cardiac disorder—Doxorubicin—uterine cancer	0.00017	0.000679	CcSEcCtD
Fluconazole—Flushing—Doxorubicin—uterine cancer	0.00017	0.000679	CcSEcCtD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00017	0.00386	CbGpPWpGaD
Fluconazole—Flatulence—Epirubicin—uterine cancer	0.00017	0.000678	CcSEcCtD
Fluconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000169	0.00385	CbGpPWpGaD
Fluconazole—Tension—Epirubicin—uterine cancer	0.000169	0.000675	CcSEcCtD
Fluconazole—Dysgeusia—Epirubicin—uterine cancer	0.000169	0.000674	CcSEcCtD
Fluconazole—Nervousness—Epirubicin—uterine cancer	0.000167	0.000669	CcSEcCtD
Fluconazole—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000167	0.0038	CbGpPWpGaD
Fluconazole—Back pain—Epirubicin—uterine cancer	0.000166	0.000666	CcSEcCtD
Fluconazole—Angiopathy—Doxorubicin—uterine cancer	0.000166	0.000664	CcSEcCtD
Fluconazole—Dizziness—Etoposide—uterine cancer	0.000166	0.000663	CcSEcCtD
Fluconazole—Immune system disorder—Doxorubicin—uterine cancer	0.000165	0.000661	CcSEcCtD
Fluconazole—CYP3A7—Metapathway biotransformation—AKR1C3—uterine cancer	0.000165	0.00376	CbGpPWpGaD
Fluconazole—Mediastinal disorder—Doxorubicin—uterine cancer	0.000165	0.000659	CcSEcCtD
Fluconazole—Chills—Doxorubicin—uterine cancer	0.000164	0.000656	CcSEcCtD
Fluconazole—CYP2C19—Metapathway biotransformation—AKR1B1—uterine cancer	0.000163	0.00372	CbGpPWpGaD
Fluconazole—Alopecia—Doxorubicin—uterine cancer	0.000162	0.000646	CcSEcCtD
Fluconazole—Mental disorder—Doxorubicin—uterine cancer	0.00016	0.000641	CcSEcCtD
Fluconazole—CYP2C9—Metapathway biotransformation—AKR1B10—uterine cancer	0.00016	0.00365	CbGpPWpGaD
Fluconazole—Ill-defined disorder—Epirubicin—uterine cancer	0.00016	0.000639	CcSEcCtD
Fluconazole—Vomiting—Etoposide—uterine cancer	0.000159	0.000637	CcSEcCtD
Fluconazole—Malnutrition—Doxorubicin—uterine cancer	0.000159	0.000637	CcSEcCtD
Fluconazole—Anaemia—Epirubicin—uterine cancer	0.000159	0.000636	CcSEcCtD
Fluconazole—Agitation—Epirubicin—uterine cancer	0.000158	0.000633	CcSEcCtD
Fluconazole—Rash—Etoposide—uterine cancer	0.000158	0.000632	CcSEcCtD
Fluconazole—Dermatitis—Etoposide—uterine cancer	0.000158	0.000631	CcSEcCtD
Fluconazole—Headache—Etoposide—uterine cancer	0.000157	0.000628	CcSEcCtD
Fluconazole—Flatulence—Doxorubicin—uterine cancer	0.000157	0.000628	CcSEcCtD
Fluconazole—Tension—Doxorubicin—uterine cancer	0.000156	0.000625	CcSEcCtD
Fluconazole—Dysgeusia—Doxorubicin—uterine cancer	0.000156	0.000624	CcSEcCtD
Fluconazole—Malaise—Epirubicin—uterine cancer	0.000155	0.000621	CcSEcCtD
Fluconazole—CYP3A5—Metapathway biotransformation—AKR1C1—uterine cancer	0.000155	0.00353	CbGpPWpGaD
Fluconazole—Nervousness—Doxorubicin—uterine cancer	0.000155	0.000619	CcSEcCtD
Fluconazole—Vertigo—Epirubicin—uterine cancer	0.000155	0.000618	CcSEcCtD
Fluconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000154	0.00351	CbGpPWpGaD
Fluconazole—Leukopenia—Epirubicin—uterine cancer	0.000154	0.000616	CcSEcCtD
Fluconazole—Back pain—Doxorubicin—uterine cancer	0.000154	0.000616	CcSEcCtD
Fluconazole—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000152	0.00347	CbGpPWpGaD
Fluconazole—Convulsion—Epirubicin—uterine cancer	0.000149	0.000596	CcSEcCtD
Fluconazole—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	0.000149	0.00339	CbGpPWpGaD
Fluconazole—Nausea—Etoposide—uterine cancer	0.000149	0.000595	CcSEcCtD
Fluconazole—Hypertension—Epirubicin—uterine cancer	0.000149	0.000594	CcSEcCtD
Fluconazole—Ill-defined disorder—Doxorubicin—uterine cancer	0.000148	0.000591	CcSEcCtD
Fluconazole—Anaemia—Doxorubicin—uterine cancer	0.000147	0.000589	CcSEcCtD
Fluconazole—Myalgia—Epirubicin—uterine cancer	0.000147	0.000586	CcSEcCtD
Fluconazole—Agitation—Doxorubicin—uterine cancer	0.000146	0.000585	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000146	0.000582	CcSEcCtD
Fluconazole—Discomfort—Epirubicin—uterine cancer	0.000145	0.000579	CcSEcCtD
Fluconazole—Malaise—Doxorubicin—uterine cancer	0.000144	0.000574	CcSEcCtD
Fluconazole—Dry mouth—Epirubicin—uterine cancer	0.000143	0.000573	CcSEcCtD
Fluconazole—Vertigo—Doxorubicin—uterine cancer	0.000143	0.000572	CcSEcCtD
Fluconazole—Leukopenia—Doxorubicin—uterine cancer	0.000143	0.00057	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—NDUFB11—uterine cancer	0.000142	0.00324	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—SRD5A2—uterine cancer	0.000142	0.00324	CbGpPWpGaD
Fluconazole—Anaphylactic shock—Epirubicin—uterine cancer	0.00014	0.000562	CcSEcCtD
Fluconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000138	0.00315	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000138	0.00315	CbGpPWpGaD
Fluconazole—Convulsion—Doxorubicin—uterine cancer	0.000138	0.000552	CcSEcCtD
Fluconazole—Nervous system disorder—Epirubicin—uterine cancer	0.000138	0.000551	CcSEcCtD
Fluconazole—Thrombocytopenia—Epirubicin—uterine cancer	0.000138	0.00055	CcSEcCtD
Fluconazole—Hypertension—Doxorubicin—uterine cancer	0.000138	0.00055	CcSEcCtD
Fluconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000137	0.00312	CbGpPWpGaD
Fluconazole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000137	0.00311	CbGpPWpGaD
Fluconazole—Skin disorder—Epirubicin—uterine cancer	0.000136	0.000546	CcSEcCtD
Fluconazole—CYP3A5—Metapathway biotransformation—GPX3—uterine cancer	0.000136	0.0031	CbGpPWpGaD
Fluconazole—Hyperhidrosis—Epirubicin—uterine cancer	0.000136	0.000543	CcSEcCtD
Fluconazole—Myalgia—Doxorubicin—uterine cancer	0.000136	0.000542	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000135	0.000538	CcSEcCtD
Fluconazole—Discomfort—Doxorubicin—uterine cancer	0.000134	0.000536	CcSEcCtD
Fluconazole—Anorexia—Epirubicin—uterine cancer	0.000134	0.000535	CcSEcCtD
Fluconazole—Dry mouth—Doxorubicin—uterine cancer	0.000133	0.00053	CcSEcCtD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000131	0.00297	CbGpPWpGaD
Fluconazole—CYP3A7—Biological oxidations—CYP19A1—uterine cancer	0.000131	0.00297	CbGpPWpGaD
Fluconazole—Anaphylactic shock—Doxorubicin—uterine cancer	0.00013	0.00052	CcSEcCtD
Fluconazole—CYP3A7—Metapathway biotransformation—CYP19A1—uterine cancer	0.000129	0.00293	CbGpPWpGaD
Fluconazole—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	0.000128	0.00292	CbGpPWpGaD
Fluconazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000128	0.000512	CcSEcCtD
Fluconazole—Nervous system disorder—Doxorubicin—uterine cancer	0.000127	0.00051	CcSEcCtD
Fluconazole—Thrombocytopenia—Doxorubicin—uterine cancer	0.000127	0.000509	CcSEcCtD
Fluconazole—Insomnia—Epirubicin—uterine cancer	0.000127	0.000508	CcSEcCtD
Fluconazole—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	0.000126	0.00288	CbGpPWpGaD
Fluconazole—Skin disorder—Doxorubicin—uterine cancer	0.000126	0.000505	CcSEcCtD
Fluconazole—Paraesthesia—Epirubicin—uterine cancer	0.000126	0.000504	CcSEcCtD
Fluconazole—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000126	0.00287	CbGpPWpGaD
Fluconazole—Hyperhidrosis—Doxorubicin—uterine cancer	0.000126	0.000502	CcSEcCtD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	0.000125	0.00285	CbGpPWpGaD
Fluconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000125	0.00285	CbGpPWpGaD
Fluconazole—Somnolence—Epirubicin—uterine cancer	0.000125	0.000499	CcSEcCtD
Fluconazole—Anorexia—Doxorubicin—uterine cancer	0.000124	0.000495	CcSEcCtD
Fluconazole—Dyspepsia—Epirubicin—uterine cancer	0.000124	0.000494	CcSEcCtD
Fluconazole—Decreased appetite—Epirubicin—uterine cancer	0.000122	0.000488	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000121	0.000485	CcSEcCtD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000121	0.00276	CbGpPWpGaD
Fluconazole—Fatigue—Epirubicin—uterine cancer	0.000121	0.000484	CcSEcCtD
Fluconazole—Pain—Epirubicin—uterine cancer	0.00012	0.00048	CcSEcCtD
Fluconazole—Constipation—Epirubicin—uterine cancer	0.00012	0.00048	CcSEcCtD
Fluconazole—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	0.00012	0.00273	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	0.000119	0.00272	CbGpPWpGaD
Fluconazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000118	0.000474	CcSEcCtD
Fluconazole—Insomnia—Doxorubicin—uterine cancer	0.000118	0.00047	CcSEcCtD
Fluconazole—Paraesthesia—Doxorubicin—uterine cancer	0.000117	0.000467	CcSEcCtD
Fluconazole—Feeling abnormal—Epirubicin—uterine cancer	0.000116	0.000463	CcSEcCtD
Fluconazole—Somnolence—Doxorubicin—uterine cancer	0.000116	0.000462	CcSEcCtD
Fluconazole—Gastrointestinal pain—Epirubicin—uterine cancer	0.000115	0.000459	CcSEcCtD
Fluconazole—Dyspepsia—Doxorubicin—uterine cancer	0.000114	0.000458	CcSEcCtD
Fluconazole—Decreased appetite—Doxorubicin—uterine cancer	0.000113	0.000452	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000112	0.000449	CcSEcCtD
Fluconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000112	0.00255	CbGpPWpGaD
Fluconazole—Fatigue—Doxorubicin—uterine cancer	0.000112	0.000448	CcSEcCtD
Fluconazole—Urticaria—Epirubicin—uterine cancer	0.000112	0.000446	CcSEcCtD
Fluconazole—Pain—Doxorubicin—uterine cancer	0.000111	0.000444	CcSEcCtD
Fluconazole—Constipation—Doxorubicin—uterine cancer	0.000111	0.000444	CcSEcCtD
Fluconazole—Abdominal pain—Epirubicin—uterine cancer	0.000111	0.000444	CcSEcCtD
Fluconazole—Body temperature increased—Epirubicin—uterine cancer	0.000111	0.000444	CcSEcCtD
Fluconazole—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	0.000109	0.00249	CbGpPWpGaD
Fluconazole—Feeling abnormal—Doxorubicin—uterine cancer	0.000107	0.000428	CcSEcCtD
Fluconazole—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000106	0.000425	CcSEcCtD
Fluconazole—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000106	0.0024	CbGpPWpGaD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—AKT1—uterine cancer	0.000105	0.0024	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	0.000105	0.0024	CbGpPWpGaD
Fluconazole—Hypersensitivity—Epirubicin—uterine cancer	0.000104	0.000414	CcSEcCtD
Fluconazole—Urticaria—Doxorubicin—uterine cancer	0.000103	0.000413	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—STAR—uterine cancer	0.000103	0.00234	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—AKR1B1—uterine cancer	0.000103	0.00234	CbGpPWpGaD
Fluconazole—Abdominal pain—Doxorubicin—uterine cancer	0.000103	0.000411	CcSEcCtD
Fluconazole—Body temperature increased—Doxorubicin—uterine cancer	0.000103	0.000411	CcSEcCtD
Fluconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000102	0.00232	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000102	0.00232	CbGpPWpGaD
Fluconazole—Asthenia—Epirubicin—uterine cancer	0.000101	0.000403	CcSEcCtD
Fluconazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000101	0.00229	CbGpPWpGaD
Fluconazole—Pruritus—Epirubicin—uterine cancer	9.94e-05	0.000397	CcSEcCtD
Fluconazole—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	9.91e-05	0.00226	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	9.83e-05	0.00224	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	9.78e-05	0.00222	CbGpPWpGaD
Fluconazole—Diarrhoea—Epirubicin—uterine cancer	9.61e-05	0.000384	CcSEcCtD
Fluconazole—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	9.6e-05	0.00218	CbGpPWpGaD
Fluconazole—Hypersensitivity—Doxorubicin—uterine cancer	9.58e-05	0.000383	CcSEcCtD
Fluconazole—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	9.43e-05	0.00215	CbGpPWpGaD
Fluconazole—Asthenia—Doxorubicin—uterine cancer	9.33e-05	0.000373	CcSEcCtD
Fluconazole—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	9.3e-05	0.00212	CbGpPWpGaD
Fluconazole—Dizziness—Epirubicin—uterine cancer	9.29e-05	0.000371	CcSEcCtD
Fluconazole—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	9.23e-05	0.0021	CbGpPWpGaD
Fluconazole—Pruritus—Doxorubicin—uterine cancer	9.2e-05	0.000368	CcSEcCtD
Fluconazole—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	9.04e-05	0.00206	CbGpPWpGaD
Fluconazole—Vomiting—Epirubicin—uterine cancer	8.93e-05	0.000357	CcSEcCtD
Fluconazole—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	8.91e-05	0.00203	CbGpPWpGaD
Fluconazole—Diarrhoea—Doxorubicin—uterine cancer	8.89e-05	0.000356	CcSEcCtD
Fluconazole—Rash—Epirubicin—uterine cancer	8.86e-05	0.000354	CcSEcCtD
Fluconazole—Dermatitis—Epirubicin—uterine cancer	8.85e-05	0.000354	CcSEcCtD
Fluconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	8.82e-05	0.00201	CbGpPWpGaD
Fluconazole—Headache—Epirubicin—uterine cancer	8.8e-05	0.000352	CcSEcCtD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.8e-05	0.002	CbGpPWpGaD
Fluconazole—Dizziness—Doxorubicin—uterine cancer	8.6e-05	0.000344	CcSEcCtD
Fluconazole—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	8.42e-05	0.00192	CbGpPWpGaD
Fluconazole—Nausea—Epirubicin—uterine cancer	8.34e-05	0.000334	CcSEcCtD
Fluconazole—Vomiting—Doxorubicin—uterine cancer	8.26e-05	0.00033	CcSEcCtD
Fluconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	8.26e-05	0.00188	CbGpPWpGaD
Fluconazole—Rash—Doxorubicin—uterine cancer	8.2e-05	0.000328	CcSEcCtD
Fluconazole—Dermatitis—Doxorubicin—uterine cancer	8.19e-05	0.000327	CcSEcCtD
Fluconazole—Headache—Doxorubicin—uterine cancer	8.14e-05	0.000326	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—POLD1—uterine cancer	8.08e-05	0.00184	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.02e-05	0.00183	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	7.78e-05	0.00177	CbGpPWpGaD
Fluconazole—Nausea—Doxorubicin—uterine cancer	7.72e-05	0.000309	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—AKR1C1—uterine cancer	7.56e-05	0.00172	CbGpPWpGaD
Fluconazole—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	7.29e-05	0.00166	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	7.21e-05	0.00164	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	7.21e-05	0.00164	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	7.19e-05	0.00164	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—NDUFB11—uterine cancer	7.01e-05	0.0016	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—SRD5A2—uterine cancer	7.01e-05	0.0016	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—RRM2—uterine cancer	6.74e-05	0.00153	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	6.65e-05	0.00151	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	6.56e-05	0.00149	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	6.55e-05	0.00149	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—DCN—uterine cancer	6.54e-05	0.00149	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.36e-05	0.00145	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.36e-05	0.00145	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	6.33e-05	0.00144	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—CXCL8—uterine cancer	6.17e-05	0.0014	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—CYP11A1—uterine cancer	6.16e-05	0.0014	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	6.11e-05	0.00139	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	5.96e-05	0.00136	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.9e-05	0.00134	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.88e-05	0.00134	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	5.87e-05	0.00134	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—AKR1C3—uterine cancer	5.82e-05	0.00132	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.8e-05	0.00132	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.8e-05	0.00132	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	5.78e-05	0.00132	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	5.55e-05	0.00126	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—AKR1B1—uterine cancer	5.07e-05	0.00115	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—STAR—uterine cancer	5.07e-05	0.00115	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—SRD5A2—uterine cancer	5.07e-05	0.00115	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—NDUFB11—uterine cancer	5.07e-05	0.00115	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—VEGFA—uterine cancer	5.01e-05	0.00114	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.67e-05	0.00106	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—STK11—uterine cancer	4.54e-05	0.00103	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—CYP19A1—uterine cancer	4.54e-05	0.00103	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.39e-05	0.000998	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	4.37e-05	0.000995	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.33e-05	0.000984	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.26e-05	0.000969	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.26e-05	0.000969	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.06e-05	0.000924	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—POLD1—uterine cancer	3.98e-05	0.000905	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—SRD5A2—uterine cancer	3.92e-05	0.000892	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—NDUFB11—uterine cancer	3.92e-05	0.000892	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—SRD5A2—uterine cancer	3.82e-05	0.00087	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—NDUFB11—uterine cancer	3.82e-05	0.00087	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.81e-05	0.000866	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—AKR1C1—uterine cancer	3.72e-05	0.000847	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	3.69e-05	0.00084	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—STAR—uterine cancer	3.66e-05	0.000834	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—AKR1B1—uterine cancer	3.66e-05	0.000834	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.59e-05	0.000818	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—SRD5A2—uterine cancer	3.57e-05	0.000813	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—NDUFB11—uterine cancer	3.57e-05	0.000813	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.47e-05	0.00079	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—MTHFR—uterine cancer	3.41e-05	0.000775	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—RRM2—uterine cancer	3.32e-05	0.000755	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.28e-05	0.000746	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—DCN—uterine cancer	3.22e-05	0.000733	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	3.21e-05	0.00073	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CYP11A1—uterine cancer	3.03e-05	0.00069	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3e-05	0.000683	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.97e-05	0.000676	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—POLD1—uterine cancer	2.88e-05	0.000654	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—AKR1C3—uterine cancer	2.86e-05	0.000652	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.83e-05	0.000645	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—STAR—uterine cancer	2.83e-05	0.000645	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.81e-05	0.000639	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.8e-05	0.000637	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—STAR—uterine cancer	2.77e-05	0.000629	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—AKR1B1—uterine cancer	2.77e-05	0.000629	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.74e-05	0.000623	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—AKR1C1—uterine cancer	2.69e-05	0.000612	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.61e-05	0.000594	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—STAR—uterine cancer	2.58e-05	0.000588	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—AKR1B1—uterine cancer	2.58e-05	0.000588	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.55e-05	0.000581	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.47e-05	0.000562	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—RRM2—uterine cancer	2.4e-05	0.000545	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.36e-05	0.000536	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.36e-05	0.000536	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—DCN—uterine cancer	2.33e-05	0.00053	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—STK11—uterine cancer	2.23e-05	0.000508	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CYP19A1—uterine cancer	2.23e-05	0.000508	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—POLD1—uterine cancer	2.22e-05	0.000506	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CYP11A1—uterine cancer	2.19e-05	0.000499	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—POLD1—uterine cancer	2.17e-05	0.000494	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.1e-05	0.000478	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—AKR1C1—uterine cancer	2.08e-05	0.000473	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—AKR1C3—uterine cancer	2.07e-05	0.000471	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—AKR1C1—uterine cancer	2.03e-05	0.000462	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—POLD1—uterine cancer	2.03e-05	0.000461	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.93e-05	0.000439	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.9e-05	0.000431	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PTEN—uterine cancer	1.9e-05	0.000431	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.87e-05	0.000425	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—RRM2—uterine cancer	1.85e-05	0.000422	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—RRM2—uterine cancer	1.81e-05	0.000412	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—EP300—uterine cancer	1.81e-05	0.000411	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—DCN—uterine cancer	1.8e-05	0.000409	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—DCN—uterine cancer	1.76e-05	0.0004	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—STAR—uterine cancer	1.7e-05	0.000388	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.7e-05	0.000388	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.7e-05	0.000386	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—RRM2—uterine cancer	1.69e-05	0.000385	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—MTHFR—uterine cancer	1.68e-05	0.000382	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CYP11A1—uterine cancer	1.65e-05	0.000376	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—DCN—uterine cancer	1.64e-05	0.000373	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.61e-05	0.000367	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—STK11—uterine cancer	1.61e-05	0.000367	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.6e-05	0.000364	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.58e-05	0.000359	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—AKR1C3—uterine cancer	1.56e-05	0.000356	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.55e-05	0.000352	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.46e-05	0.000332	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PIK3CA—uterine cancer	1.34e-05	0.000304	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—POLD1—uterine cancer	1.34e-05	0.000304	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.25e-05	0.000285	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.25e-05	0.000284	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—STK11—uterine cancer	1.25e-05	0.000284	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—STK11—uterine cancer	1.22e-05	0.000277	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CYP19A1—uterine cancer	1.22e-05	0.000277	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—MTHFR—uterine cancer	1.21e-05	0.000276	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.17e-05	0.000266	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.14e-05	0.000259	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—STK11—uterine cancer	1.14e-05	0.000259	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.12e-05	0.000254	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—RRM2—uterine cancer	1.11e-05	0.000254	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—AKT1—uterine cancer	1.09e-05	0.000249	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—DCN—uterine cancer	1.08e-05	0.000246	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.07e-05	0.000243	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.02e-05	0.000232	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.02e-05	0.000232	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—AKR1C3—uterine cancer	9.63e-06	0.000219	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—MTHFR—uterine cancer	9.37e-06	0.000213	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PTEN—uterine cancer	9.33e-06	0.000212	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—MTHFR—uterine cancer	9.15e-06	0.000208	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—EP300—uterine cancer	8.9e-06	0.000202	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—MTHFR—uterine cancer	8.55e-06	0.000194	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.26e-06	0.000188	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.53e-06	0.000171	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CYP19A1—uterine cancer	7.5e-06	0.000171	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—STK11—uterine cancer	7.5e-06	0.000171	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PTEN—uterine cancer	6.74e-06	0.000153	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PIK3CA—uterine cancer	6.58e-06	0.00015	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—EP300—uterine cancer	6.43e-06	0.000146	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—MTHFR—uterine cancer	5.64e-06	0.000128	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—AKT1—uterine cancer	5.38e-06	0.000122	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PTEN—uterine cancer	5.21e-06	0.000119	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PTEN—uterine cancer	5.09e-06	0.000116	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—EP300—uterine cancer	4.97e-06	0.000113	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—EP300—uterine cancer	4.85e-06	0.00011	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PIK3CA—uterine cancer	4.76e-06	0.000108	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PTEN—uterine cancer	4.75e-06	0.000108	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—EP300—uterine cancer	4.53e-06	0.000103	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—AKT1—uterine cancer	3.89e-06	8.84e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PIK3CA—uterine cancer	3.68e-06	8.37e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PIK3CA—uterine cancer	3.59e-06	8.17e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PIK3CA—uterine cancer	3.35e-06	7.63e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PTEN—uterine cancer	3.14e-06	7.13e-05	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—AKT1—uterine cancer	3e-06	6.84e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—EP300—uterine cancer	2.99e-06	6.8e-05	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—AKT1—uterine cancer	2.93e-06	6.67e-05	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—AKT1—uterine cancer	2.74e-06	6.23e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.21e-06	5.03e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—AKT1—uterine cancer	1.81e-06	4.11e-05	CbGpPWpGaD
